SFA Therapeutics

company

About

SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$4M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4M
SFA Therapeutics has raised a total of $4M in funding over 2 rounds. Their latest funding was raised on Jun 20, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 20, 2022 Seed $4M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
SFA Therapeutics is funded by 1 investors. Savantus Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Savantus Ventures Seed